Four School of Medicine faculty members have been selected to receive 2023 Physician-Scientist “Strong Start” awards.

How our bodies sense our environment and react to it is a big question, and how we answer it can have important implications for drug development.

Current medical standards for accessing stroke risk perform worse for Black Americans than they do for white Americans, potentially creating a self-perpetuating driver of health inequities.

Three individuals and two teams within the School of Medicine are among Duke’s 2022-23 Presidential Award winners. 

As chief operating officer at the Duke Human Vaccine Institute (DHVI), Thomas Denny is in the unique position of helping people fight flu and HIV, developing the next generation of COVID-19 vaccines, and all the while leading an annual $120 million enterprise.

Duke cancer biologist Jason Somarelli, PhD, will collaborate with a group of Duke marine scientists to explore the cellular adaptations that some whales possess that gives them such an amazing ability to tolerate low-oxygen (hypoxic) environments as they dive and forage for food.

Enthusiasm for applying AI tools to some of healthcare’s most vexing problems is helping drive the adoption of technologies that, until relatively recently, had not undergone the kinds of rigorous scrutiny routinely applied to drugs and medical devices.

Betty Staples, MD, and Jane Gagliardi, MD, are recipients of a one-year $50,000 Josiah Macy Jr. Foundation Catalyst Award for Transformation in Graduate Medical Education.

For the first time since 2019, the Duke Cancer Institute Scientific Retreat was held in person with a full program followed by a poster session and mingling. Held on December 2, 2022, the retreat attracted around 90 faculty, staff, and trainees.

Dean Klotman is joined by Duke cardiologist Christopher Granger, MD, to discuss the importance of getting trained in rapid hands-only CPR.